15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Natures Sunshine Products Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $25.00 to $36.00, a moderate spread. The average target of $30.50 sits 121% above the current $13.83. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.28 next quarter toward $1.23 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Natures Sunshine Products Inc.
As of Sep, 2 of 2 firms rate NATR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NATR EPS & revenue forecast
EPS · NEXT QUARTER
$0.28
Range $0.26 – $0.30 · 2 analysts · -7% YoY
Next period, 2 analysts expect Natures Sunshine Products Inc to earn $0.28 a share (range $0.26 – $0.30), versus $0.30 a year earlier. Full-year consensus is $1.08, growing to $1.23 the year after.
REVENUE · NEXT QUARTER
$126.3M
Range $126.3M – $126.4M · 2 analysts · +2% YoY
Revenue is expected to reach $126.3M (range $126.3M – $126.4M), +2.1% year-over-year. Full-year consensus is $495.7M, rising to $519.2M next year.
Top analysts covering Natures Sunshine Products Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NATR.
#1
Linda Bolton Weiser
DA Davidson · Rank #393
Buy
$19.00+37.4% to target
Overall win rate
29%
+ Follow
#2
Susan Anderson
Canaccord Genuity · Rank #411
Buy
$36.00+160.3% to target
Overall win rate
29%
+ Follow
#3
BH
Brian Holland
DA Davidson
Buy
$33.00+138.6% to target
Coverage
—
+ Follow
#4
MC
Matt Curtis
DA Davidson
Buy
$25.00+80.8% to target
Coverage
—
+ Follow
NATR stock forecast FAQ
What is NATR's average 12-month price target?+
The 2 analysts with a live target average $30.50 for Natures Sunshine Products Inc over the next 12 months, ranging from a $36.00 high to a $25.00 low.
Is NATR stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NATR?+
The Street-high target is $36.00 (Canaccord Genuity), and the Street-low is $25.00 (DA Davidson). The average of all 2 active targets is $30.50.
How many Wall Street analysts cover NATR?+
2 analysts have an active rating on Natures Sunshine Products Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering NATR?+
Among analysts who currently cover NATR, Linda Bolton Weiser of DA Davidson has the strongest overall Quantellect track record (Rank #393). Their current call is Buy with a $19.00 target.
What is Natures Sunshine Products Inc's projected EPS for next quarter?+
The consensus estimate is $0.28 per share (range $0.26 – $0.30) across 2 analysts. Full-year EPS is projected at $1.08, rising to $1.23 the following year.
How much revenue is Natures Sunshine Products Inc expected to report next quarter?+
Consensus revenue is $126.3M (range $126.3M – $126.4M). Full-year revenue is projected at $495.7M, growing to $519.2M next year.
Have analysts been upgrading or downgrading NATR lately?+
As of Sep, 2 of 2 firms rate NATR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NATR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
